Chemotherapy regimen
“The Study on Current Treatment Pattern and Outcome of Chemotherapy regimen in Multiple Myeloma Patients in Tertiary Care Cancer Hospital: A Prospective and Observational Study” by Arya S Baiju, Umesh Yadav, Prashant Kumar Sah, Dr. Dharshini N M, Mrs. Mahadevamma L, India.
... The diagnostic criteria as recommended were based on clinical information such as serum monoclonal protein, serum free light chain (kappa and lambda). During the monthly cycle of treatment patients were followed of ...
5
Effect of neoadjuvant chemotherapy regimen on relapse free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de escalation of neoadjuvant chemotherapy
... of chemotherapy response include ultrasound of both breast and axilla [24], dynamic contrast-enhanced magnetic resonance imaging (MRI) [29], MRI texture analysis [25], and tri- modal imaging (ultrasound, ...
10
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
... induction chemotherapy, use of rituximab with induction, number of pre-ASCT chemotherapy regimens (not counting mobilization), response to induction therapy, preparatory regimen for ASCT, and ...
33
Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response
... best chemotherapy regimen as assessed in the MiCK assay and overall survival both in all ovarian cancer patients studied, and in the more homogeneous subset of patients with chemotherapy-naïve stage ...
8
The efficacy of sodium azulene sulfonate L-glutamine for managing chemotherapy-induced oral mucositis in cancer patients: a prospective comparative study
... normal chemotherapy regimen (i.e., not high-dose chemotherapy or combined radiation therapy) ...treatment regimen, but it is clearly exacerbated in regimens involv- ing fluorinated pyrimidine ...
6
Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
... Our thrombosis rate was lower than the 18% reported by the MSKCC group [14]. Many factors could have contributed to this lower rate, including a lower risk- patient population enrolled and different diagnostic methods. ...
7
Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children
... cumulative chemotherapy in advanced-stage HL patients and to enhance early response through a dose- dense chemotherapy regimen (adriamycin, bleomycin, vincristine, etoposide, prednisone, ...
7
Combination therapy with brentuximab vedotin and cisplatin/cytarabine in a patient with primarily refractory anaplastic lymphoma kinase positive anaplastic large cell lymphoma
... multidrug chemotherapy regimen used for the treatment of aggressive lymphoma, DHAP, can be efficiently and safely combined as salvage treatment prior to autologous stem cell transplantation in a case of ...
5
Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
... of chemotherapy programs were used in this study, including CVP (cyclophosphamide, vincristine, and predni- sone), CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone), chlorambucil and fludarabine, ...
15
Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
... combination chemotherapy in 53 cases of advanced lung ...peutic regimen resulted in an RR of ...the chemotherapy side effects, which was especially important in those patients completing the ...
7
The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting
... multiday chemotherapy, 4) received oral chemotherapy alone or in combination with an IV formula- tion, 5) switched from a single-day-per-cycle chemotherapy regimen to multiday ...
14
Preliminary Economic Evaluation of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: An "Early Look" Model Based on Phase II Results
... in chemotherapy regimen since the same billing code may refer to more than one chemotherapy ...for chemotherapy do not specify the chemotherapy type, name or dose and hence, the cost of ...
108
<p>Prognostic Significance Of Platelet-To-Lymphocyte Ratio (PLR) And Mean Platelet Volume (MPV) During Etoposide-Based First-Line Treatment In Small Cell Lung Cancer Patients</p>
... rst-line chemotherapy regimen, fi rst evaluation result and radiotherapy ...of chemotherapy, including total white blood cell count (WBC), absolute neutrophil count (NEUT), absolute lym- phocyte count ...
11
Efficacy of pemetrexed-based regimen in relapsed advanced thymic epithelial tumors and its association with thymidylate synthase level
... standard chemotherapy regimen has been identified in the relapsed ...pemetrexed-based regimen in advanced TET as palliative treatment after failure of previous chemotherapy, and to detect its ...
5
Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
... every 3 weeks)]. The exclusion criteria were as follows. ① Patients with diarrhea before chemotherapy. ② Patients with other intestinal diseases, such as ulcerative colitis and Crohn’s disease. ③ Alternation of ...
10
IL-10 and PRKDC polymorphisms are associated with glioma patient survival
... and chemotherapy regimen, we found that the median overall survival (OS) of WHO grade I–II glioma patients (12 months; 3-year survival rate = ...was chemotherapy, in all glioma ...with ...
8
CHEMOTHERAPY UTILIZATION OF BREST CANCER IN CANCER CENTER, THAILAND
... describe chemotherapy utilization situation of breast cancer patients after NHSO cancer protocol version 2010 had been ...3,485 chemotherapy prescriptions of out-patient departments between January to June ...
5
Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO
... vival was not significantly different (P ⴝ .16). At 4 years, 28% of PAdriaCEBO patients and 50% of PMitCEBO patients were alive (P ⴝ .0001). Ann Arbor stage III/IV, World Health Organization perfor- mance status 2-4, and ...
8
Review Article Meta-analysis of hypofractionated radiotherapy versus conventional radiotherapy in locally advanced non-small-cell lung cancer
... with chemotherapy is the main treatment regimen, and according to the RTOG 7,301 trial, conven- tional radiotherapy uses fractionated radiation doses of 60 to 66 Gy and 2 Gy per fraction ...
10
NEOSCOPE: A randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma
... OXCAP chemotherapy (oxaliplatin 130 mg/m2 D1, Cape 625 mg/m 2 D1-21, q 3 wk), patients are randomised 1:1 to OXCAP-RT (oxaliplatin 85 mg/m 2 Day 1,15,29; capecitabine 625 mg/m 2 twice daily on days of RT; RT-45 ...
9